|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-11-28
|
|
pubmed:abstractText |
To assess the effectiveness and tolerability of caspofungin as primary prophylaxis against invasive fungal infections in stem cell transplant recipients who are poor candidates for triazole or lipid amphotericin B prophylaxis due to renal or hepatic dysfunction, and to determine whether any patient characteristics are independently associated with an increased risk of breakthrough invasive fungal infection during caspofungin prophylaxis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0277-0008
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1644-50
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18041885-Adult,
pubmed-meshheading:18041885-Aged,
pubmed-meshheading:18041885-Antibodies, Monoclonal,
pubmed-meshheading:18041885-Antifungal Agents,
pubmed-meshheading:18041885-Cancer Care Facilities,
pubmed-meshheading:18041885-Echinocandins,
pubmed-meshheading:18041885-Female,
pubmed-meshheading:18041885-Graft vs Host Disease,
pubmed-meshheading:18041885-Humans,
pubmed-meshheading:18041885-Immunosuppressive Agents,
pubmed-meshheading:18041885-Liver Failure,
pubmed-meshheading:18041885-Male,
pubmed-meshheading:18041885-Middle Aged,
pubmed-meshheading:18041885-Multivariate Analysis,
pubmed-meshheading:18041885-Mycoses,
pubmed-meshheading:18041885-Opportunistic Infections,
pubmed-meshheading:18041885-Pseudomonas Infections,
pubmed-meshheading:18041885-Renal Insufficiency,
pubmed-meshheading:18041885-Retrospective Studies,
pubmed-meshheading:18041885-Stem Cell Transplantation,
pubmed-meshheading:18041885-Time Factors
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
|
|
pubmed:affiliation |
Division of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
